BNO - Good Profits Ahead, page-12

Holders of millions of shares, perhaps.
On BNO's value: Now that BNC210 appears to have failed beyond hope of recovery - although not yet certain it does seem likely - at what SP would I consider buying back in? Well, BNO has modest revenues from the likes of Merck and ?grants which give it something like 5-20m pa. On a very general rule of thumb, that puts its value somewhere around 5-20m or 1-4c per share plus whatever its continuing product pipelines are worth. With 210 failing and a ?cancer drug before that I'm not sure why one would still have faith in the others in the pipeline, so there's no point at which I'll buy back in unless there's a significant change.
[Apologies for not updating sentiment for my previous post]